Quantisnow Logo
Dashboard

SEC Form SC 13G/A filed by Stryker Corporation (Amendment)

$SYK
Medical/Dental Instruments
Health Care
Get the next $SYK alert in real time by email
SC 13G/A 1 filingtext2021.txt SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 Amendment No. |15| Stryker Corporation (Name of Issuer) Common Stock, $.10 Par Value (Title of Class of Securities) 863667101 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,see the Notes). -------------------------------------------------------------------------------- CUSIP No. 863667101 13G/A Page 2 of 6 Pages ________________________________________________________________________________ 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Greenleaf Trust 38-3416104 ________________________________________________________________________________ 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] Not Applicable (b) [_] ________________________________________________________________________________ 3. SEC USE ONLY ________________________________________________________________________________ 4. CITIZENSHIP OR PLACE OF ORGANIZATION State of Michigan ________________________________________________________________________________ 5. SOLE VOTING POWER 114,316 NUMBER OF _________________________________________________________________ SHARES 6. SHARED VOTING POWER BENEFICIALLY OWNED BY EACH 20,338,656 REPORTING _________________________________________________________________ PERSON WITH 7. SOLE DISPOSITIVE POWER 110,066 _________________________________________________________________ 8. SHARED DISPOSITIVE POWER 20,342,906 ________________________________________________________________________________ 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 20,452,972 ________________________________________________________________________________ 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [_] ________________________________________________________________________________ 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.4% ________________________________________________________________________________ 12. TYPE OF REPORTING PERSON* BK ________________________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! -------------------------------------------------------------------------------- Item 1(a) Name of Issuer: Stryker Corporation Item 1(b) Address of Issuer's Principal Executive Offices: 2825 Airview Boulevard Kalamazoo, MI 49002 Item 2(a) Name of Person Filing: Greeneaf Trust Item 2(b) Address of Principal Business Office or, if None, Residence: 211 South Rose Street Kalamazoo, MI 49007 Item 2(c) Citizenship: State of Michigan Item 2(d) Title of Class of Securities: Common Stock, $.10 Par Value Item 2(e) CUSIP Number: 863667101 -------------------------------------------------------------------------------- Item 3. If this statement is filed pursuant to Rules 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) [_] Broker or dealer registered under Section 15 of the Act (15 U.S.C.78o); (b) [X] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C.78c); (c) [_] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C.78c); (d) [_] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C.8a-8); (e) [ ] An Investment Adviser in accordance with Section 240. 13d-1(b)(1) (ii)(E); (f) [_] An employee benefit plan or endowment fund in accordance with Section 240. 13d-1(b)(1)(ii)(F); (g) [_] A parent holding company or control person in accordance with Section 240. 13d-1(b)(1)(ii)(G); (h) [_] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [_] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C.80a-3); (j) [_] Group, in accordance with Section 240. 13d-1(b)(1)(ii)(J). If this statement is filed pursuant to Section 240 13d-1(c), check this box. [ ] Item 4. Ownership. (a) Amount beneficially owned: 20,452,972 (b) Percent of class: 5.4% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote 114,316 (ii) Shared power to vote or to direct the vote 20,338,656 (iii) Sole power to dispose or to direct the disposition of 110,066 (iv) Shared power to dispose or to direct the disposition of 20,342,906 -------------------------------------------------------------------------------- Item 5. Ownership of Five Percent or Less of a Class. Not Applicable If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ]. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Greenleaf Trust holds these securities in a fiduciary capacity on behalf of various trust and investment management customers, some of whom have the right to receive, or the power to direct the receipt of, dividends from or the proceeds from the sale of these securities Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not Applicable Item 8. Identification and Classification of Members of the Group. Not Applicable Item 9. Notice of Dissolution of Group. Not Applicable Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect. -------------------------------------------------------------------------------- SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 11, 2022 (Date) /s/ Michael F. Odar ----------------------------- (Signature) Michael F. Odar, President Greenleaf Trust (Name/Title)
Get the next $SYK alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$SYK

DatePrice TargetRatingAnalyst
2/26/2025$450.00Buy
Citigroup
12/2/2024$370.00 → $445.00Equal-Weight → Overweight
Morgan Stanley
9/10/2024$405.00Outperform
Wolfe Research
5/30/2024$372.00Neutral
Goldman
5/22/2024$392.00Hold → Buy
Needham
1/31/2024$315.00 → $360.00Hold → Buy
Canaccord Genuity
10/20/2023$345.00Buy
ROTH MKM
9/5/2023$310.00 → $315.00Neutral → Buy
BofA Securities
More analyst ratings

$SYK
 Press Releases

Fastest customizable press release news feed in the world

See more

  • Stryker to announce financial results for its first quarter of fiscal year 2025

    Portage, Michigan, April 07, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its first quarter of fiscal year 2025 on Thursday, May 1, 2025.  A press release will be issued at approximately 4:05 p.m. ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company's first quarter that ended March 31, 2025. Stryker will host a webcast at 4:30 p.m. ET on Thursday, May 1, 2025, to discuss its first quarter 2025 results.  The webcast can be accessed at Stryker - Events & Presentations.  An archive of the webcast will also be available on the company's website two hours after the

    $SYK
    Medical/Dental Instruments
    Health Care

  • Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC

    VB Spine is a Strategic Partner to Stryker with Access to Mako Spine and Copilot Marc, John and Anthony Viscogliosi Lead VB Spine as Co-Chief Executive Officers NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Viscogliosi Brothers, LLC, a family-owned investment office specializing in the neuro-musculoskeletal space, today announced the successful completion of its previously announced acquisition of the U.S. spine business from Stryker (NYSE:SYK). The business will operate as a standalone company under the name VB Spine, LLC ("VB Spine"). VB Spine is advancing toward the completion of its acquisition of Stryker's international spine businesses, pending satisfaction of legal and regul

    $SYK
    Medical/Dental Instruments
    Health Care

  • Stryker completes sale of U.S. spinal implants business

    Portage, Michigan, April 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today that it has completed the sale of its U.S. spinal implants business to Viscogliosi Brothers, LLC, as part of the newly formed company VB Spine, LLC. "The sale of our spinal implants business enhances our strategic focus, positioning us to meet evolving customer needs and invest where we see the greatest opportunity for innovation and long-term growth," said Kevin Lobo, Chair and CEO, Stryker. "We remain committed to the spine space through our Interventional Spine, Neurotechnology and Enabling Technologies businesses, as well as our strategic partnership with

    $SYK
    Medical/Dental Instruments
    Health Care

$SYK
 Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$SYK
 Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$SYK
 SEC Filings

See more

$SYK
 Leadership Updates

Live Leadership Updates

See more

  • Stryker showcases next generation of Mako SmartRobotics™ at AAOS 2025 Annual Meeting

    Latest technology offers more applications and innovation across more specialties MAHWAH, N.J., March 11, 2025 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, showcases the latest advancements in Mako SmartRobotics™ across hip, knee, spine and shoulder procedures at the American Academy of Orthopaedic Surgeons' (AAOS) 2025 Annual Meeting in San Diego. With over 1.5 million Mako procedures performed globally across 45 countries, Mako is a market-leading technology in orthopaedics. With the introduction of Mako Total Hip with Advanced Primary and Rev

    $SYK
    Medical/Dental Instruments
    Health Care

  • Kadant Set to Join S&P SmallCap 600

    NEW YORK, Feb. 13, 2025 /PRNewswire/ -- Kadant Inc. (NYSE:KAI) will replace Inari Medical Inc. (NASD: NARI) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, February 19. S&P 500 constituent Stryker Corp. (NYSE:SYK) is acquiring Inari Medical in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name      Action Company Name Ticker GICS Sector February 19, 2025 S&P SmallCap 600 Addition Kadant KAI Industrials February 19, 2025 S&P SmallCap 600 Deletion Inari Medical NARI Health Care For more information about

    $KAI
    $NARI
    $SPGI
    $SYK
    Industrial Machinery/Components
    Industrials
    Medical/Dental Instruments
    Health Care

  • Stryker announces the retirement of Glenn S. Boehnlein and the promotion of Preston Wells to Vice President, Chief Financial Officer

    Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that Glenn S. Boehnlein will retire from his role as Vice President, Chief Financial Officer. Boehnlein's decision follows an impressive 22-year career at Stryker. Preston Wells, who currently serves as Group CFO for Stryker's Orthopaedics Group, will assume the role of Vice President, Chief Financial Officer effective April 1, 2025. "I want to thank Glenn for his performance drive, strong business partnership, and excellent leadership of the Finance and IT organizations. Glenn is a growth champion who invested in developing talent, including Preston Wells, who has been promoted to Chief Financial Offi

    $SYK
    Medical/Dental Instruments
    Health Care

$SYK
 Financials

Live finance-specific insights

See more

  • Stryker completes acquisition of Inari Medical, Inc., providing entry into the high-growth peripheral vascular segment

    Portage, Michigan, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today that it has completed the acquisition of Inari Medical, Inc. (NASDAQ:NARI), a company that provides innovative solutions for venous thromboembolism (VTE) clot removal without the use of thrombolytic drugs. The addition of Inari brings an established peripheral vascular position to Stryker in the fast-growing VTE segment. "The acquisition of Inari Medical marks a significant milestone in expanding our interventional endovascular portfolio," said Kevin Lobo, Chair and Chief Executive Officer, Stryker. "We look forward to welcoming the talented Inari team to Stryk

    $NARI
    $SYK
    Medical/Dental Instruments
    Health Care

  • Stryker declares an $0.84 per share quarterly dividend

    Portage, Michigan, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.84 per share payable April 30, 2025 to shareholders of record at the close of business on March 31, 2025, representing an increase of 5.0% versus the prior year and unchanged from the previous quarter.  About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 15

    $SYK
    Medical/Dental Instruments
    Health Care

  • Stryker reports 2024 operating results and 2025 outlook

    Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024: Fourth Quarter Results Reported net sales increased 10.7% to $6.4 billionOrganic net sales increased 10.2%Reported operating income margin of 9.0%Adjusted operating income margin(1) increased 200 bps to 29.2%Reported EPS decreased 52.7% to $1.41Adjusted EPS(1) increased 15.9% to $4.01  Fourth Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        10.6        %         (0.5)        %         11.1        %         1.0        %         10.1        

    $SYK
    Medical/Dental Instruments
    Health Care

$SYK
 Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more